p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy

被引:157
作者
Zwang, Yaara [1 ]
Yarden, Yosef [1 ]
机构
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
关键词
chemotherapy; EGFR; endocytosis; UV; TNF;
D O I
10.1038/sj.emboj.7601297
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The epidermal growth factor receptor (EGFR) frequently associates with cancer and already serves as a target for therapy. We report that inflammatory cytokines and ultraviolet (UV) irradiation respectively induce transient or sustained phosphorylation of EGFR. Subsequently, EGFR internalizes via a Clathrin-mediated process. In cytokine-stimulated cells, EGFR recycles back to the cell surface, whereas in irradiated cells it arrests in Rab5-containing endosomes. Under both conditions, receptor internalization is instigated by the p38 stress-induced kinase. The underlying mechanism entails phosphorylation of EGFR at a short segment (amino acids 1002-1022) containing multiple serines and threonines, as well as phosphorylation of two Rab5 effectors, EEA1 and GDI. Like UV irradiation, a chemotherapeutic agent activates p38 and accelerates receptor internalization. We demonstrate that abrogating EGFR internalization reduces the efficacy of chemotherapy-induced cell death. Hence, by preventing EGFR-mediated survival signaling, the internalization route we uncovered enhances the cytotoxic effect of drugs like cis-platinum, which may underlie interactions between chemotherapy and EGFR-targeting drugs.
引用
收藏
页码:4195 / 4206
页数:12
相关论文
共 30 条
[1]   Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome [J].
Bao, J ;
Alroy, I ;
Waterman, H ;
Schejter, ED ;
Brodie, C ;
Gruenberg, J ;
Yarden, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :26178-26186
[2]   Critical update and emerging trends in epidermal growth factor receptor targeting in cancer [J].
Baselga, J ;
Arteaga, CL .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2445-2459
[3]   ANTITUMOR EFFECTS OF DOXORUBICIN IN COMBINATION WITH ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODIES [J].
BASELGA, J ;
NORTON, L ;
MASUI, H ;
PANDIELLA, A ;
COPLAN, K ;
MILLER, WH ;
MENDELSOHN, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (16) :1327-1333
[4]   Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck [J].
Baselga, J ;
Trigo, JM ;
Bourhis, J ;
Tortochaux, J ;
Cortés-Funes, H ;
Hitt, R ;
Gascón, P ;
Arnellal, N ;
Harstrick, A ;
Eckardt, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5568-5577
[5]   Cisplatin-induced activation of the EGF receptor [J].
Benhar, M ;
Engelberg, D ;
Levitzki, A .
ONCOGENE, 2002, 21 (57) :8723-8731
[6]  
BIRD TA, 1989, J IMMUNOL, V142, P126
[7]  
BIRD TA, 1990, J BIOL CHEM, V265, P235
[8]   The stress-induced MAP kinase p38 regulates endocytic trafficking via the GDI:Rab5 complex [J].
Cavalli, V ;
Vilbois, F ;
Corti, M ;
Marcote, MJ ;
Tamura, K ;
Karin, M ;
Arkinstall, S ;
Gruenberg, J .
MOLECULAR CELL, 2001, 7 (02) :421-432
[9]  
Ciardiello F, 2000, CLIN CANCER RES, V6, P2053
[10]  
Ciardiello F, 2001, CLIN CANCER RES, V7, P1459